Crinetics Approach

News Releases

News Releases

July 16, 2019
Crinetics Pharmaceuticals Appoints Stephanie Okey to Board of Directors
SAN DIEGO , July 16, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced the
March 14, 2019
Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO2019
SAN DIEGO , March 14, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors, today announced four